ART
64
12
15
30
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.6%
1 terminated out of 64 trials
96.8%
+10.3% vs benchmark
8%
5 trials in Phase 3/4
10%
3 of 30 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 30 completed trials
Clinical Trials (64)
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
Standardization of Variable Conditions of Embryo Transfer Into the Uterine Cavity in the Procedure of Medically Assisted Procreation in Humans
Automation of the In Vitro Fertilization Laboratory
Delivery Optimization for Pre-Exposure Prophylaxis (DO PrEP) Study
The SMART ART Study
Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes
Strengthening Families Living With HIV in Kenya
Enhancing Management Algorithms for Children Conceived Via Assisted Reproductive Technologies
RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
Cultural Arts Programme for Older Chinese
Acceptance and Commitment Therapy and Exercise for Older Adults With Chronic Pain
Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF
Accelerated ART Initiation for PWHIV Who Are Out of Care
Goals for Adherence with Low-cost Incentives
Adenomyosis and Pregnancy Outcomes in Women Undergoing Assisted Reproductive Technology Treatment
Cardiometabolic Function in Offspring, Mother and Placenta After Assisted Reproductive Technology
Primary and Secondary Drug Resistance Mutations (DRMs) in HIV As a Risk Factor of Failure of ART, Including Two Drugs Based Regimens.
Ethanol Sclerotherapy Prior to ART
The Impact of Endometrial Compaction on Assisted Reproductive Technology Outcome
IVF Offspring Born in Guangzhou